Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive OfficerBusiness Wire•27/07/2026•08:30 ET0 ShareWhiz InsightsGenerateGet startedCreate a free account to read the full story.Sign UpAlready have an account? Log inForgot password?